Why did you choose Duke for your fellowship training?
I immediately felt at home with the Duke Gyn Onc family when I interviewed here, and being in Durham allowed me to match in the same area as my wife Sasha, who is a GI fellow at UNC.
What excites you about the fellowship program at Duke Obstetrics & Gynecology?
I'm excited about the focus on health services research that impacts practice and policy, with mentors like Dr. Havrilesky and Dr. Moss. I also love the OR and am excited about the strong balance of straight stick and robotic surgery.
What are your career goals?
I hope to practice in an academic setting, balancing an active clinical practice with time devoted to health services and clinical research and teaching/mentoring learners.
What are your hobbies?
Trail running, tennis, hiking with my wife and dogs, Luna and Omar, faithfully cheering on my home-state University of Kentucky basketball and football teams
Education & Training
Undergraduate school & graduation year:
BS Yale 2011
Medical school & graduation year:
MD Yale School of Medicine 2016,
MS The Dartmouth Institute for Health Policy 2015
Residency & graduation year:
Hospital of the University of Pennsylvania OBGYN 2020
Awards and Honors
S. Leon Israel Award, for outstanding resident research manuscript in Philadelphia 2019-2020 for "Impact of Medicaid Expansion on women with gynecologic cancer: A Difference-in-Difference Analysis", Philadelphia Obstetrical Society
Publications & Presentations
Albright BB, Wignall E, Bentley RC, Havrilesky LJ, Previs RA, Strickland KC. BAP1 tumor predisposition syndrome presenting as a recurrent ovarian sex cord-stromal tumor. Int J Gynecol Path. 2022. Online ahead of print.
Darling AJ, Albright BB, Strickland KC, Davidson BA. Molar Pregnancy: Epidemiology, Diagnosis, Management, Surveillance. Curr Obstet Gynecol Rep. 2022 June;11:133-141
Albright BB, Ling C, Havrilesky LJ, Moss HA, Wright JD. Out-of-network bills among privately insured patients undergoing hysterectomy. Am J Obstet Gynecol. 2022 Apr;226(4):543.e1-543.e45.
Peterson JA, Albright BB, Moss HA, Bianco A. Catastrophic health expenditures with pregnancy and delivery in the United States. Obstet Gynecol. 2022 Apr 1;139(4):509-520.
Albright BB, Nitecki R, Chino F, Chino JP, Havrilesky LJ, Aviki EM, Moss HA. Catastrophic health expenditures, insurance churn, and nonemployment among gynecologic cancer paitents in the United States. Am J Obstet Gynecol. 2022 Mar;226(3):384.e1-384.e13.
Nitecki R, Albright BB, Johnson MS, Moss HA. Employment outcomes among cancer patients in the United States. Cancer Epidemiol. 2022 Feb;76:102059.
Montes de Oca MK, Albright BB, Secord AA, Havrilesky LJ, Moss HA. Adjuvant treatment and outcomes for patients with stage IIIA grade 1 endometrioid endometrial cancer. Int J Gynecol Cancer. 2021 Dec;31(12):1549-1556.
Huang AB, Wu J, Chin L, Albright BB, Previs RA, Moss HA, Davidson BA, Havrilesky LJ, Melamed A, Wright JD. Neoadjuvant chemotherapy for advanced stage endometrial cancer: A systematic review. Gynecol Oncol Rep. 2021 Nov 6;38:100887.
Albright BB, Myers ER, Moss HA, Ko EM, Sonalkar S, Havrilesky LJ. Surveillance for gestational trophoblastic neoplasia following molar pregnancy: a cost-effectiveness analysis. Am J Obstet Gynecol. 2021 Nov;225(5):513.e1-513.e19..
Wright JD, Huang Y, Melamed A, Albright BB, Hillyer, GC, Previs R, Hershman DL. Use and outcomes of neoadjuvant chemotherapy for metastatic uterine cancer. Gynecol Oncol. 2021 Sep;162(3):599-605.
Albright BB, Chino F, Chino JP, Havrilesky LJ, Aviki EM, Moss HA. Insurance churn and catastrophic health expenditures among the cancer population in the United States under the Affordable Care Act. JAMA Network Open. 2021 Sep;4(9):e2124280.
Albright BB, Monuszko KA, Kaplan SJ, Davidson BA, Moss HA, Huang AB, Melamed A, Wright JD, Havrilesky LJ, Previs RA. Primary cytoreductive surgery for advanced stage endometrial cancer: a systematic review and meta-analysis. Am J Obstet Gynecol. 2021 Sep;225(3):237.e1-237.e24.
Monuszko KA, Albright BB, Montes de Oca MK, Nguyen NTT, Havrilesky LJ, Davidson BA. Evaluation of the clinical Index of Stable febrile neutropian risk stratification system for management of febrile neutropenia in gynecologic oncology patients. Gynecol Oncol Rep. 2021 Aug 27;37:100853
Albright BB, Chino F, Chino JP, Havrilesky LJ, Aviki EM, Moss HA. Medicaid expansion reduced uninsured surgical hospitalizations and associated catastrophic financial burden. Health Affairs. 2021 Aug;40(8):1294-1303.
Nasioudis D, Albright BB, Ko EM, Haggerty AF, Guintoli RL, Kim SH, Morgan MA, Latif NA. Oncologic outcomes of minimally invasive verus open radical hysterectomy for early stage cervical carcinoma and tumor size <2 cm: a systematic review and meta-analysis. Int J Gynecol Cancer. 2021 Jul;31(7):983-990.
Albright BB, Chino F, Chino JP, Havrilesky LJ, Aviki EM, Moss HA. Association of Medicaid expansion with mortality from gynecologic cancers. Am J Obstet Gynecol. 2021 Mar;224(3):323-325.
Nasioudis D, Albright BB, Haggerty AF, Ko EM, Kim SH, Morgan MA, Latif NA. Survival following minimally invasive radical hysterectomy for patients with cervical carcinoma and tumor size ≤2 cm. Am J Obstet Gynecol. 2021 Mar;224(3):317-318.e2.
Albright BB, Delgado MK, Latif NA, Giuntoli RL, Ko EM, Haggerty AF. Emergency department utilization by patients with gynecologic cancer in the United States. Int J Gynecol Cancer. 2021 Apr;31(4):585-593.
Albright BB, Nasioudis D, Craig S, Moss HA, Latif NA, Ko EM, Haggerty AF. Impact of Medicaid expansion on women with gynecologic cancer: a difference-in-difference analysis. Am J Obstet Gynecol. 2021 Feb;224(2):195.e1-195.e17.
Albright BB, Nasioudis D, Byrne ME, Latif NA, Ko EM, Haggerty AF. Perioperative outcomes and disparities in utilization of sentinel lymph node biopsy in minimally invasive staging of endometrial cancer. Gynecol Oncol. 2020 Dec;159(3):758-766.
Nasioudis D, Albright BB, Roy A, Ko EM, Guintoli RL, Haggerty AF, Cory L, Kim SH, Morgan MA, Latif NA. Patterns of use and outcomes of sentinel lymph node mapping for patients with high-grade endometrial cancer. Gynecol Oncol. 2020 Dec;159(3):732-736.
Nasioudis D, Albright BB, Ko EM, Haggerty AF, Guintoli RL, Burger RA, Morgan MA, Latif NA. Advanced stage primary mucinous ovarian carcinoma. Where do we stand ? Arch Gynecol Obstet. 2020 Apr;301(4):1047-1054.
Albright BB, Shorter JM, Mastroyannis SA, Ko EM, Schreiber CA, Sonalkar S. Gestational Trophoblastic Neoplasia After Human Chorionic Gonadotropin Normalization Following Molar Pregnancy: A Systematic Review and Meta-analysis. Obstet Gynecol. 2020 Jan;135(1):12-23.
Albright BB, Delgado MK, Latif NA, Giuntoli RL, Ko EM, Haggerty AF. Treat-and-Release Emergency Department Utilization by Patients With Gynecologic Cancers. J Oncol Pract. 2019 May;15(5):e428-e438.
Feinberg J, Albright B, Black J, Lu L, Passarelli R, Gysler S, Whicker M, Altwerger G, Menderes G, Hui P, Azodi M, Silasi D, Ratner E, Litkouhi B, Schwartz PE. Ten-Year Comparison Study of Type 1 and 2 Endometrial Cancers: Risk Factors and Outcomes. Gynecol Obstet Invest. 2019 Jan: 84(3):290-297
Nasioudis D, Mastroyannis SA, Albright BB, Haggerty AF, Ko EM, Latif NA. Adjuvant chemotherapy for stage I ovarian clear cell carcinoma: Patterns of use and outcomes. Gynecol Oncol. 2018 Jul;150(1):14-18.
Albright BB, Black JD, Passarelli R, Gysler S, Whicker M, Altwerger G, Menderes G, Buza N, Hui P, Santin AD, Azodi M, Silasi D, Ratner E, Litkouhi B, Schwartz PE. Associated characteristics and impact on recurrence and survival of free-floating tumor fragments in the lumen of fallopian tubes in Type I and Type II endometrial cancer. Gynecol Oncol Reports. 2018 Jan;23:28-33.
Newhall K, Albright B, Tosteson A, Ozanne E, Trus T, Goodney PP. Cost-effectiveness of prophylactic appendectomy: a Markov model. Surg Endosc. 2017 Sep;31(9):3596-3604.
Albright B, Dhaher R, Wang H, Harb R, Lee TSW, Zaveri H, Eid T. Progressive neuronal activation accompanies epileptogenesis caused by hippocampal glutamine synthetase inhibition. Exp Neurol. 2017 Feb;288:122-133.
Albright BB, Black JD, Vilardo N, Schwartz PE. Correction of coagulopathy associated with non-bacterial thrombotic endocarditis (NBTE) by surgical debulking in a case of ovarian clear cell carcinoma. Gynecol Oncol Reports. 2016 May;17:13-15.
Albright BB, Lewis VA, Ross JS, Colla CH. Preventive Care Quality of Medicare Accountable Care Organizations. Med Care. 2016 Mar;54(3):326-335.
Albright BB, Witte T, Tofte AN, Chou J, Black JD, Desai VB, Erekson EA. Robotic Versus Laparoscopic Hysterectomy for Benign Disease: A Systematic Review and Meta-Analysis of Randomized Trials. J Minim Invasive Gynecol. 2016 Jan;23(1):18-27.
Aviki EM, Moss HA, Albright BB, Krivovyaz L, Abu-Rustum NR, Jewell E, Leedy J, Liang MI. Overspending Driven by Dose-Specific Packaging of Lenvatinib for Endometrial Cancer. Presented at the Society of Gynecologic Oncology 53rd Annual Meeting on Women’s Cancer. Phoenix, Arizona. March 18-21, 2022.
Albright BB, Chino F, Chino JP, Havrilesky LJ, Aviki EM, Moss HA. Churn and catastrophe: Insurance loss and high spending among patients with gynecologic cancer in the United States in the era of the Affordable Care Act. Presented at the Society of Gynecologic Oncology 52nd Annual Meeting on Women’s Cancer. Virtual. March 19-25, 2021.
Albright BB and Saris D, Cory L, Giuntoli RL, Ko EM, Haggerty AF. Utilization of the Emergency Department by Gynecologic Oncology Patients: High Rates and High Needs in a medically vulnerable population. Presented at the Society of Gynecologic Oncology 51st Annual Meeting on Women’s Cancer. Virtual. March 27-31, 2020.
Health services research, quasi-experimental methods, systematic review and meta-analysis, cost-effectiveness analysis.